Q2 Financial Highlights
Group revenues in US$ up 24% year-on-year (£ revenues up 26% year-on-year)
Order backlog up more than 10% sequentially
Normalised profit before tax and earnings per share up 30% and 37% year-on-year respectively (IFRS PBT and EPS down 73% and 73% year-on-year respectively)
£41.8m costs incurred in Q2, being ARM's contribution to a full and final settlement of certain patent related litigation, charged in the IFRS reported results
Record net cash generation of £96m
Interim dividend increased by 26%
